Wells Fargo’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.5M Buy
427,489
+326,054
+321% +$14.1M ﹤0.01% 1335
2025
Q1
$3.51M Buy
101,435
+13,435
+15% +$464K ﹤0.01% 2386
2024
Q4
$2.41M Buy
88,000
+18,322
+26% +$503K ﹤0.01% 2680
2024
Q3
$1.77M Sell
69,678
-2,030
-3% -$51.7K ﹤0.01% 2829
2024
Q2
$1.82M Buy
71,708
+16,411
+30% +$416K ﹤0.01% 2780
2024
Q1
$1.71M Buy
55,297
+8,686
+19% +$269K ﹤0.01% 2804
2023
Q4
$1.88M Sell
46,611
-36,312
-44% -$1.47M ﹤0.01% 2681
2023
Q3
$2.19M Sell
82,923
-53,242
-39% -$1.4M ﹤0.01% 2550
2023
Q2
$2.34M Buy
136,165
+70,300
+107% +$1.21M ﹤0.01% 2621
2023
Q1
$1.09M Buy
65,865
+64,494
+4,704% +$1.07M ﹤0.01% 3099
2022
Q4
$10.4K Sell
1,371
-4,961
-78% -$37.8K ﹤0.01% 5214
2022
Q3
$62K Sell
6,332
-2,249
-26% -$22K ﹤0.01% 4543
2022
Q2
$77K Sell
8,581
-26,737
-76% -$240K ﹤0.01% 4534
2022
Q1
$359K Sell
35,318
-39,431
-53% -$401K ﹤0.01% 4356
2021
Q4
$1.25M Buy
74,749
+6,553
+10% +$109K ﹤0.01% 3685
2021
Q3
$3.2M Buy
68,196
+31,585
+86% +$1.48M ﹤0.01% 3101
2021
Q2
$2.23M Sell
36,611
-52,179
-59% -$3.18M ﹤0.01% 3417
2021
Q1
$5.47M Buy
88,790
+16,255
+22% +$1M ﹤0.01% 2629
2020
Q4
$5.16M Buy
72,535
+31,879
+78% +$2.27M ﹤0.01% 2696
2020
Q3
$1.53M Sell
40,656
-6,718
-14% -$252K ﹤0.01% 3469
2020
Q2
$1.55M Buy
47,374
+8,953
+23% +$292K ﹤0.01% 3405
2020
Q1
$1.11M Buy
38,421
+24,431
+175% +$708K ﹤0.01% 3389
2019
Q4
$490K Buy
13,990
+844
+6% +$29.6K ﹤0.01% 4288
2019
Q3
$282K Buy
+13,146
New +$282K ﹤0.01% 4598